(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Israeli police block Latin Patriarch from Palm Sunday mass in Jerusalem - 2Figure out How to Pick a Crematorium: Key Contemplations.
- 3How do my eyes adjust to the dark and how long does it take?
- 47 Well known Vacation spots In The US
- 5U.S. to drop childhood vaccine recommendations as it looks to Denmark, Washington Post reports
- Don't fall for it: These common tourist scams in Rome are easy to avoid if you know what you're looking for
- Best Amusement Park Bite: What Do You Very much want to Crunch On?
- Seoul says sorry after unapproved drone flights into North Korea
- Scientists detect X-ray glow from interstellar comet 3I/ATLAS extending 250,000 miles into space
- Parents search for children missing since a volcanic eruption in Colombia 40 years ago
- Scientists map of old Mars river basins for the 1st time. These could be great places to search for ancient life
- Figure out how to Amplify Your Open Record Reward
- Step by step instructions to Guarantee Your Lab Precious stone is Morally Obtained
- Misjudged Objections For Solo Voyagers
